Neogen Chemicals Limited - Neraca (Quarterly)

Neogen Chemicals Limited
IN ˙ NSEI
₹ 1,486.65 ↑11.60 (0.79%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Neogen Chemicals Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash 19 5 16 328 35 182 54 122 63 50
Change (%) -72.73 214.27 1,946.42 -89.33 420.57 -70.25 125.65 -48.81 -20.77
Assets Current 2,353 2,402 3,132 4,925 5,768 6,558 7,223 7,837 7,730 9,998
Change (%) 2.05 30.40 57.25 17.13 13.70 10.13 8.50 -1.36 29.35
Assets 3,884 4,920 6,045 7,994 9,027 10,538 12,020 14,614 15,503 17,473
Change (%) 26.65 22.87 32.25 12.92 16.74 14.06 21.58 6.09 12.71
Liabilities 2,186 3,090 4,082 3,602 4,494 5,713 7,046 7,011 7,731 9,579
Change (%) 41.34 32.12 -11.76 24.77 27.12 23.33 -0.49 10.27 23.90
Equity 1,698 1,830 1,963 4,392 4,533 4,825 4,974 7,603 7,772 7,894
Change (%) 7.75 7.27 123.75 3.20 6.44 3.09 52.84 2.22 1.57
Liabilities And Stock Equity 3,884 4,920 6,045 7,994 9,027 10,538 12,020 14,614 15,503 17,473
Change (%) 26.65 22.87 32.25 12.92 16.74 14.06 21.58 6.09 12.71

Source: Capital IQ

Other Listings
IN:542665
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista